Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced − Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengthened by additional analyses and ...

Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...

Early one morning, while checking on a slumbering patient at the Center for Sleep Medicine, Erik St. Louis, M.D., noticed something peculiar. The patient, a woman in her early 60's, had started ...

HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...

The American M270 MLRS or Multiple Launch Rocket System is one of the most powerful rocket systems in NATO's arsenal. Adopted by the US and Western Europe in the 1980s, it was developed to counter the ...

Amazon unveiled a new robotics system for its warehouses that can pick, sort and consolidate packages in a single assembly line. The system is called Blue Jay, and Amazon said it's already being ...

Physical AI holds the promise of making everything from robots to a slew of mobile edge devices much more interactive and useful, but it will significantly alter how systems are designed, verified, ...

After menopause, women with multiple sclerosis experienced accelerated volume loss in global gray matter, the left hippocampus, and the left anterior cingulate, highlighting the menopausal transition ...

L3Harris Technologies has unveiled a new generation of its counter-unmanned systems platform that includes specialized land, maritime, air, and electronic warfare variants. The move reflects the ...

Microsoft is investigating a bug that causes Copilot issues when multiple Office apps are running simultaneously on the same system. According to a support document published on Friday, this bug ...

VALBY, Denmark, Oct. 2, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that pipeline developments regarding amlenetug, a novel investigational molecule for the potential treatment of ...